NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

February 1, 2027

Study Completion Date

September 1, 2027

Conditions
Glioblastoma Multiforme
Interventions
DEVICE

NanoTherm therapy

Cyclic hyperthermia in patients with recurrent glioblastoma multiforme, who underwent implantation of iron oxide nanoparticles.

PROCEDURE

Glioma Resection

Removal of brain tumor - gross total ressection

RADIATION

radiotherapy according to Stupp protocol

The total dose according to the Stupp protocol is 60 Gy and is administered in fractions of 2 Gy per day for 5 days (Monday to Friday) for 6 weeks.

DRUG

chemotherapy according to Stupp protocol

Temozolomide is used during radiotherapy: 75 mg/m2 of body surface area per day for 7 days a week. After the completion of radiotherapy, temozolomide is used as adjuvant therapy - 6 cycles of 150-200 mg/m2 of body surface area for 5 days every 28 days.

Trial Locations (1)

60-355

RECRUITING

University Hospital, Poznan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

MagForce USA

INDUSTRY

lead

Poznan University of Medical Sciences

OTHER